Stock listing

Plus Therapeutics, Inc.

Selected listing: PSTV · BOATS · USD · US

Plus Therapeutics, Inc. (BOATS:PSTV), Health Technology. Latest release Jul 31, 2026: Cerenome Launches as an Integrated CNS Oncology Company.

PSTV:BOATSUSDUSUpdated August 31, 2026

Ticker: BOATS:PSTV
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BOATS
Currency: USD

About Plus Therapeutics, Inc.

Plus Therapeutics, Inc. is a public company traded under the ticker PSTV in the American market. Plus Therapeutics focuses on developing innovative treatments for cancer and other serious diseases.

Latest news from Plus Therapeutics, Inc.

Cerenome Launches as an Integrated CNS Oncology Company

July 31, 2026

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

July 28, 2026

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

July 21, 2026

Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

July 16, 2026

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

July 14, 2026

All Plus Therapeutics, Inc. news →

Events

Replays

PLUS THERAPEUTICS, Inc. (PSTV) Q4 2024 Earnings Call
Thu, Mar 27, 2025 · 05:00 PM ET
Watch
PLUS THERAPEUTICS, Inc. (PSTV) Q3 2024 Earnings Call
Thu, Nov 14, 2024 · 05:00 PM ET
Watch
PLUS THERAPEUTICS, Inc. (PSTV) Q2 2024 Earnings Call
Wed, Aug 14, 2024 · 05:00 PM ET
Watch

Research Plus Therapeutics, Inc.

Plus Therapeutics, Inc. company profile

View the public company page for Plus Therapeutics, Inc. on 6ix.

Plus Therapeutics, Inc. news

Read company news and market updates connected to Plus Therapeutics, Inc..

Plus Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Plus Therapeutics, Inc..